Search results
Tematy dnia
1 dzień temu · A Phase 2 Double-Blind, Placebo-Controlled Study Showing Oral Tableted Norovirus Vaccine VXA-G1.1-NN is Immunogenic, Efficacious, and Reduces Viral Shedding Following Norovirus Challenge. Poster #220 presented at IDWeek 2024. October 16-19, 2024. Los Angeles, CA.
27 lut 2024 · Outbreaks of norovirus, which causes vomiting and diarrhea, are on the rise. What to know about the 2024 norovirus season in the US, symptoms, and prevention.
4 dni temu · SOUTH SAN FRANCISCO, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that it will present research demonstrating the potential of its norovirus oral pill ...
29 maj 2024 · Norovirus is a leading cause of acute gastroenteritis (AGE) worldwide, causing ~685 million cases annually1. Each year, an estimated 1.5 million deaths occur globally due to all-cause AGE2, with...
24 lut 2024 · Cases of norovirus are on the rise in the US, on par with seasonal trends, according to the most recent data from the US Centers for Disease Control and Prevention. In the week ending February...
We report an increase in GII.17 norovirus outbreaks and sporadic infections of acute gastroenteritis in Austria, Germany, France, Ireland, the Netherlands, England and the United States during the 2023/24 season.
